SODIUM VALPROATE WOCKHARDT sodium valproate 1000 mg/10 mL solution for injection ampoule Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 400 mg/4 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE JUNO sodium valproate 400 mg/4mL solution for injection, ampoule Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sodium valproate juno sodium valproate 400 mg/4ml solution for injection, ampoule

juno pharmaceuticals pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: water for injections - sodium valproate juno is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; nitrogen - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible

VALPROATE-AFT sodium valproate 400 mg/4 ml solution for intravenous infusion or injection ampoules Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 400 mg/4 ml solution for intravenous infusion or injection ampoules

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: monobasic potassium phosphate; dibasic sodium phosphate dodecahydrate; water for injections; nitrogen - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection ampoules Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection ampoules

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: dibasic sodium phosphate dodecahydrate; nitrogen; water for injections; monobasic potassium phosphate - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 400 mg/4 ml solution for intravenous infusion or injection vials Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 400 mg/4 ml solution for intravenous infusion or injection vials

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; monobasic potassium phosphate; dibasic sodium phosphate dodecahydrate; nitrogen - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible

VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection ampoules Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 300 mg/3 ml solution for intravenous infusion or injection ampoules

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: nitrogen; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection vial Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection vial

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; nitrogen; monobasic potassium phosphate; dibasic sodium phosphate dodecahydrate - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible

VALWOK sodium valproate 1000 mg/10 mL solution for injection ampoule Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

valwok sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - valwok is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.